Mark Agulnik, MD, City of Hope Comprehensive Cancer Center joins Targeted Oncology for a discussion about the sarcoma treatment landscape and pending innovations under investigation in clinical trials.

In season 3, episode 1 of Targeted Talks, Michael A. Postow, MD, discusses available targeted agents for BRAF-mutant melanoma and ongoing clinical questions about treating the disease.

Sandra P. D'Angelo, MD and Katherine Poruk, MD

In season 2, episode 9 of Targeted Talks, Sandy Srinivas, MD and Nicholas J. Vogelzang, MD, discuss he optimal sequencing of therapies for a specific patient with metastatic castration-resistant prostate cancer.

In season 2, episode 8 of “Targeted Talks,” Thomas Hutson, DO, PharmD, and Rana R. McKay, MD, of UC San Diego Health, discussed the renal cell carcinoma paradigm and challenges to overcome in the future.

In season 2, episode 8 of Targeted Talks, Jeff Yorio, MD, and Douglas Johnson, MD, MSCI, joins us for a talk around recent advances in immunotherapy for melanoma.

In season 2, episode 6 of Targeted Talks, Dr. Michael J. Overman joins us for a special discussion around rare genomic alterations in colorectal cancer.

In season 2, episode 6 of Targeted Talks, Alexander B. Olawaiye, MD leads a discussion with Haider S. Mahdi, MD, about the modern approaches to treating cervical and endometrial cancers.

In season 2, episode 4 of Targeted Talks, Benjamin O. Anderson, MD, FACS, discussed the lessons learned from the COVID-19 pandemic, and preparation for a post-COVID America.

Jason Luke, MD, leads a discussion with Sandip Patel, MD, about the present and future of immunotherapy in cancer.